Hillman Solutions (HLMN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
21 Apr, 2026Executive summary
Achieved record 2025 net sales of $1.552 billion, up 5.4% year-over-year, and record adjusted EBITDA of $275.3 million, up 13.9% from 2024.
Returned to profitability with 2025 net income of $40.3 million, up from $17.3 million in 2024, and Q4 net income of $1.6 million, reversing a prior year loss.
Successfully navigated tariff impacts and maintained strong customer service, with pricing actions offsetting higher costs.
2026 guidance targets net sales of $1.6–$1.7 billion and adjusted EBITDA of $275–$285 million, with continued focus on new business wins, operational efficiency, and strategic M&A.
Management expects continued top and bottom line growth, supported by ongoing investments and supply chain diversification.
Financial highlights
2025 net sales rose by $80 million, driven by acquisitions, new business, and pricing, despite a 5% decline in market volumes.
Adjusted gross profit margin for 2025 increased 60 bps to 48.7%; adjusted EBITDA margin improved to 17.7% from 16.4%.
Adjusted diluted EPS for 2025 was $0.58, up from $0.49 in 2024; Q4 adjusted EPS was flat at $0.10.
Free cash flow for 2025 was $35.1 million, impacted by $65 million in tariffs; net debt reduced to $665.8 million.
Free cash flow conversion for 2025 was 30%, down from 101% in 2024.
Outlook and guidance
2026 net sales guidance: $1.6–$1.7 billion (midpoint $1.65 billion), up 6.3% at midpoint.
2026 adjusted EBITDA guidance: $275–$285 million (midpoint $280 million).
2026 free cash flow guidance: $100–$120 million, with over 90% conversion of adjusted net income.
Adjusted gross margin expected to normalize to 46–47% in 2026, with Q1 as the low point due to high-cost inventory.
CapEx planned at $70–$75 million for 2026, focused on MiniKey 3.5 expansion and merchandising solutions.
Latest events from Hillman Solutions
- Net sales rose 3% to $370.1M, but net loss widened and EBITDA declined amid cost pressures.HLMN
Q1 202628 Apr 2026 - Shareholders will virtually vote on directors, executive pay, and auditor, with all proposals recommended for approval.HLMN
Proxy filing22 Apr 2026 - Five-year plan targets $2.5B sales by 2030 with 8–12% CAGR and strong margin expansion.HLMN
Investor Day 202620 Mar 2026 - Record Q3 sales and EBITDA growth led to raised guidance and improved leverage metrics.HLMN
Q3 202517 Mar 2026 - Q2 net income and EBITDA rose on flat sales; profit outlook up, sales guidance down.HLMN
Q2 20242 Feb 2026 - Net income and EBITDA rose in Q3 2024, with higher guidance and a $7.8M True Value charge.HLMN
Q3 202416 Jan 2026 - Q1 sales and EBITDA grew, guidance held, but free cash flow pulled due to tariff risks.HLMN
Q1 202527 Dec 2025 - Record EBITDA, margin gains, and improved profitability set stage for 2025 growth.HLMN
Q4 202423 Dec 2025 - Shareholders will vote on director elections, compensation, share plans, and auditor ratification.HLMN
Proxy Filing2 Dec 2025